Skip to main navigation Skip to search Skip to main content

Abnormalities in parentally rated executive function in methamphetamine/polysubstance exposed children

  • Brian J. Piper
  • , Summer F. Acevedo
  • , Galena K. Kolchugina
  • , Robert W. Butler
  • , Selena M. Corbett
  • , Elizabeth B. Honeycutt
  • , Michael J. Craytor
  • , Jacob Raber

Research output: Contribution to journalArticlepeer-review

Abstract

Methamphetamine/polysubstance abuse in women of childbearing age is a major concern because of the potential long-term detrimental effects on the brain function of the fetus following in utero exposure. A battery of established tests, including the Wechsler Abbreviated Scale of Intelligence, Conners' Continuous Performance Test II, Behavioral Rating Inventory of Executive Function, the CMS Family Pictures and Dot Location tests, the Spatial Span test from the WISC-IV-Integrated, and a recently developed spatial learning and memory measure (Memory Island), was used to assess the effects of prenatal drug exposure on neurobehavioral performance. Participants were 7 to 9 year old children from similar socioeconomic backgrounds who either had (N = 31) or had not (N = 35) been exposed to methamphetamine/polysubstance during pregnancy. Compared to unexposed children, exposed children showed pronounced elevations (i.e. more problems) in parental ratings of executive function, including behavioral regulation and metacognition. Exposed children also exhibited subtle reductions in spatial performance in the Memory Island test. In contrast, IQ, Spatial Span, Family Pictures, Dot Location, and vigilance performance were unaffected by prenatal drug exposure history. Thus, children of women who reported using methamphetamine and other recreational drugs during pregnancy showed a selective profile of abnormalities in parentally rated executive function.

Original languageEnglish (US)
Pages (from-to)432-439
Number of pages8
JournalPharmacology Biochemistry and Behavior
Volume98
Issue number3
DOIs
StatePublished - May 2011

Funding

This research was supported by the National Institute of Drug Abuse ( L30 DA027582-01 , T32 DA07262 and 1P50DA018165 ), the National Institute of Environmental Health Sciences ( T32 ES007060 ), a Public Health Service Grant ( 1 UL1 RR024120-01 & UL1 RR024140 ), the Ellison Medical Foundation ( AG-NS-0201 ), and the Clinical Research Enhancement Fund ( 90120298 ). Anthony Bader, Hilary Gray, Paige Cooper and Collin Clifford provided technical assistance. Finally, we acknowledge Bob Ritchie of the Ponce School of Medicine/RCMI Publications Office (Grant # 5G12RR003050-25 ) for his help with the manuscript preparation.

FundersFunder number
National Institute on Drug AbuseL30 DA027582-01, 1P50DA018165, T32 DA07262
National Institutes of Health/National Institute of Environmental Health SciencesT32 ES007060
National Center for Research ResourcesUL1RR024140
Ellison Medical FoundationAG-NS-0201, 90120298
U.S. Public Health Service1 UL1 RR024120-01, UL1 RR024140

    Keywords

    • Alcohol
    • Learning
    • Neuropsychology
    • Nicotine

    ASJC Scopus subject areas

    • Biochemistry
    • Toxicology
    • Pharmacology
    • Clinical Biochemistry
    • Biological Psychiatry
    • Behavioral Neuroscience

    Fingerprint

    Dive into the research topics of 'Abnormalities in parentally rated executive function in methamphetamine/polysubstance exposed children'. Together they form a unique fingerprint.

    Cite this